1.5.1 Aminosalicylates
Mesalazine
Mezavant XL 1200mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Octasa 1600mg MR gastro-resistant tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Octasa 400mg MR gastro-resistant tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Octasa 800mg MR gastro-resistant tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Pentasa 1g modified-release granules sachets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Pentasa 1g modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Pentasa 2g modified-release granules sachets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Pentasa 4g modified-release granules sachets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Pentasa 500mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Salofalk 1.5g gastro-resistant modified-release granules sachets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Salofalk 1g gastro-resistant modified-release granules sachets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Salofalk 1g gastro-resistant tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Salofalk 1g suppositories
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Salofalk 1g/application foam enema
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Salofalk 2g/59ml enema
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Salofalk 3g gastro-resistant modified-release granules sachets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Salofalk 500mg gastro-resistant modified-release granules sachets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Salofalk 500mg gastro-resistant tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Salofalk 500mg suppositories
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
Sulfasalazine
Sulfasalazine 250mg/5ml oral suspension sugar free
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Sulfasalazine 500mg gastro-resistant tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Sulfasalazine 500mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Ulcerative colitis / Inflammatory bowel disease |